Clorox Co (NYSE:CLX) reported better-than-expected earnings for the fourth quarter on Monday.

The company posted quarterly earnings of $1.66 per share which beat the analyst consensus estimate of $1.65 per share. The company reported quarterly sales of $1.948 billion which beat the analyst consensus estimate of $1.898 billion.

Clorox said it sees FY2027 adjusted EPS of $5.70-$6.00, versus market estimates of $5.97. The company expects sales of $7.594 billion-$7.661 billion, versus estimates of $7.501 billion.

“Our fourth-quarter results were in line with our expectations and reflect disciplined execution in a dynamic environment,” said Chair and CEO Linda Rendle. “Throughout fiscal year 2026, we strengthened our business despite continued consumer and macroeconomic pressures. We expanded our portfolio through the acquisition of GOJO Industries, completed our U.S. ERP implementation, a foundational modernization of the systems and processes that underpin every aspect of our operations, while advancing our digital capabilities. Together, these actions have strengthened our foundation and position us well to navigate a challenging operating environment as we work to return to organic sales growth.”

Clorox shares rose 1.8% to $100.00 in pre-market trading.

These analysts made changes to their price targets on Clorox following earnings announcement.

  • Evercore ISI Group analyst Javier Escalante maintained the stock with an Underperform rating and raised the price target from $98 to $99.
  • Wells Fargo analyst Chris Carey maintained the stock with an Equal-Weight rating and raised the price target from $95 to $102.

Considering buying CLX stock? Here’s what analysts think:

Photo via Shutterstock